MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6306-1329-1337$20.00
Mol Pharmacol 63:1329-1337, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vailati, S.
Right arrow Articles by Gotti, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vailati, S.
Right arrow Articles by Gotti, C.

Developmental Expression of Heteromeric Nicotinic Receptor Subtypes in Chick Retina

S. Vailati, M. Moretti, R. Longhi, G. E. Rovati, F. Clementi, and C. Gotti

Consiglio Nazionale delle Ricerche (CNR), Institute of Neuroscience, Cellular and Molecular Pharmacology Section, Department of Medical Pharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milan, Milan, Italy (S.V., M.M., F.C., C.G.); CNR Center of Hormone Chemistry, Milan, Italy (R.L.); and Laboratory of Molecular Pharmacology, Department of Pharmacological Sciences, University of Milan, Italy (G.E.R.)

Acting through nicotinic acetylcholine receptors (nAChRs), acetylcholine plays an important role in retinal development and the formation of retinal connections to target tissues, but very little is known about the nAChR subtypes expressed in vertebrate retina during neuronal development. We used immunoprecipitation and [3H]epibatidine binding to study the expression of chick retina {alpha}-bungarotoxin–insensitive heteromeric nAChRs during development and adulthood, and found that it is strictly developmentally regulated, reaching a peak on postnatal day 1. The increase in [3H]epibatidine receptors is caused mainly by an increase in the receptors containing the {alpha}2, {alpha}6, {beta}3, and {beta}4 subunits. The contribution of {beta} subunits to [3H]epibatidine receptors significantly changes during development: the {beta}2 subunit is contained in the majority (84%) of receptors on embryonic day (E) 7 but in only 32% on postnatal day (P) 1, whereas the {beta}4-containing receptors increase from 22% to 78% during the same period. Using a sequential immunodepletion procedure, we purified the {beta}2- and {beta}4-containing subtypes and found that they coassemble with {alpha}4 and/or {alpha}3 on E11, and also with the {alpha}2, {alpha}6, and {beta}3 on P1. After the immunodepletion of {alpha}6-containing receptors, the {beta}2- and {beta}4-containing receptors have a very similar pharmacological profile on P1. Parallel immunoprecipitation experiments in other brain areas showed that the developmentally regulated receptors in optic lobe are those containing the {alpha}2, {alpha}5, and {beta}2 subunits and those containing the {alpha}4 and {beta}2 subunits, whereas the receptors in forebrain-cerebellum contain the {alpha}4 and {beta}2 subunits with or without the {alpha}5 subunit. These results indicate that there is an increase in receptor heterogeneity and complexity in chick retina during development that is also maintained in adulthood.


Received January 13, 2003; accepted February 12, 2003

Address correspondence to: Dr. Cecilia Gotti, CNR, Institute of Neuroscience, Section of Cellular and Molecular Pharmacology, Department of Medical Pharmacology, University of Milan, Via Vanvitelli 32, 20129 Milano, Italy. E-mail: c.gotti{at}csfic.mi.cnr.it




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. M. Marritt, B. C. Cox, R. P. Yasuda, J. M. McIntosh, Y. Xiao, B. B. Wolfe, and K. J. Kellar
Nicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes
Mol. Pharmacol., December 1, 2005; 68(6): 1656 - 1668.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. R. Turner and K. J. Kellar
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
J. Neurosci., October 5, 2005; 25(40): 9258 - 9265.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J.-Z. Guo, Y. Liu, E. M. Sorenson, and V. A. Chiappinelli
Synaptically Released and Exogenous ACh Activates Different Nicotinic Receptors to Enhance Evoked Glutamatergic Transmission in the Lateral Geniculate Nucleus
J Neurophysiol, October 1, 2005; 94(4): 2549 - 2560.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, A. Zanardi, A. Gaimarri, N. Champtiaux, J.-P. Changeux, P. Whiteaker, M. J. Marks, F. Clementi, and M. Zoli
Heterogeneity and Selective Targeting of Neuronal Nicotinic Acetylcholine Receptor (nAChR) Subtypes Expressed on Retinal Afferents of the Superior Colliculus and Lateral Geniculate Nucleus: Identification of a New Native nAChR Subtype {alpha}3{beta}2({alpha}5 or {beta}3) Enriched in Retinocollicular Afferents
Mol. Pharmacol., October 1, 2005; 68(4): 1162 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Moretti, S. Vailati, M. Zoli, G. Lippi, L. Riganti, R. Longhi, A. Viegi, F. Clementi, and C. Gotti
Nicotinic Acetylcholine Receptor Subtypes Expression during Rat Retina Development and Their Regulation by Visual Experience
Mol. Pharmacol., July 1, 2004; 66(1): 85 - 96.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Wehrwein, S. A. Thompson, S. F. Coulibaly, D. M. Linn, and C. L. Linn
Acetylcholine Protection of Adult Pig Retinal Ganglion Cells from Glutamate-Induced Excitotoxicity
Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1531 - 1543.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics